U-Shaped Association Seen for Alcohol Consumption, Cardiometabolic Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, Dec. 6, 2024 -- There is a U-shaped association between alcohol consumption and coronary heart disease (CHD) and type 2 diabetes (T2D) but no evidence for a causal association, according to a study published online Nov. 24 in Alcohol: Clinical and Experimental Research.
Rachel L. Kember, Ph.D., from Crescenz Veterans Affairs Medical Center in Philadelphia, and colleagues conducted two retrospective nested case-control studies of 33,053 CHD and 28,278 T2D cases matched to five controls each to examine observed and genetically proxied associations between alcohol consumption and the incidence of CHD and T2D in African Americans (AAs), European Americans (EAs), and Hispanic Americans (HAs). Alcohol exposure was estimated using the Alcohol Use Disorders Identification Test-Consumption score closest in time prior to the index date. Mendelian randomization analyses used a single variant in ADH1B or a genetic score as instrumental variables.
The researchers found a U-shaped association of alcohol consumption with CHD and T2D risk in an observational analysis. In Mendelian randomization analyses, there was no association for ADH1B genotype-predicted (in AAs, EAs, and HAs) nor genetic score-predicted (in EAs) alcohol consumption with CHD risk. There was also no association for T2D with alcohol consumption predicted by the ADH1B genotype (in AAs, EAs, or HAs) or genetic score (in EAs). There was no association between alcohol consumption and cardiometabolic diseases in multivariable Mendelian randomization analyses adjusted for the effects of blood pressure and smoking.
"Our results suggest that, as has been shown in larger population groups, there are not beneficial effects of moderate alcohol consumption on cardiometabolic disease," the authors write.
One author disclosed ties to relevant organizations.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
GLP-1 Receptor Agonist Use Linked to Reduced Overall Risk for Cancer in Adults With Obesity
TUESDAY, Aug. 26, 2025 -- For adults with obesity, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced overall risk for cancer, including lower...
MedDiet Plus Energy Reduction, Physical Activity Cuts Incidence of Type 2 Diabetes
TUESDAY, Aug. 26, 2025 -- For individuals with overweight or obesity and metabolic syndrome, an intensive intervention combining energy reduction, the Mediterranean diet...
Seniors With Certain Cardiovascular Diseases Saw Life's Essential 8 Scores Decline 2013 to 2018
WEDNESDAY, Aug. 20, 2025 -- From 2013 to 2018, older adults with heart failure, stroke, and hypertension experienced significant declines in Life's Essential 8 (LE8) scores...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.